VSIR and systemic lupus erythematosus: Meanwhile, activation of PD-1H with monoclonal antibodies reduced skin symptoms and decreased multiple autoimmune markers including autoantibodies, inflammatory cytokines and chemokines in lupus mice, suggesting that activation of PD-1H has a significant immunosuppressive effect (47).